Physician profile
Blake Singletary
NPI 1316341787
$9,460.12
in general payments reported to CMS, 2019-2025
32 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $1,583 · 2021: $1,633 · 2022: $555 · 2023: $817 · 2024: $697 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,273 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,272.82 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,614.21 | 2019-2024 | Jot Dx, Aveir, Mitraclip |
| Cardiovascular Systems INC. | $1,104.38 | 2019-2021 | |
| Terumo Medical Corporation | $532.09 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $457.51 | 2024-2025 | |
| Bolton Medical INC | $424.21 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $398.99 | 2021-2025 | Lifevest |
| Pfizer INC. | $390.60 | 2019-2025 | |
| Boston Scientific Corporation | $373.35 | 2019-2021 | |
| Shockwave Medical, INC | $359.50 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $305.70 | 2019-2020 | |
| Amgen INC. | $295.55 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $258.88 | 2020-2025 | Farxiga |
| Philips North America LLC | $239.80 | 2024-2025 | Igt Devices Undivided, (Ck7) Extended Holter, Ecc Solutions |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.11 | 2022-2025 | Jardiance |
| Cook Medical LLC | $169.99 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $151.85 | 2019 | |
| Abiomed | $134.30 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $134.11 | 2022-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $119.54 | 2021 | |
| Inari Medical, INC. | $114.63 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $90.75 | 2023-2025 | Onpattro |
| Biotronik INC. | $89.29 | 2021-2023 | Biomonitor |
| Getinge USA Sales, LLC | $85.55 | 2019 | |
| Cardinal Health 200 LLC | $67.07 | 2020 | |
| Esperion Therapeutics, INC. | $65.37 | 2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $64.93 | 2019 | |
| Bridgebio Pharma, INC. | $52.47 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $44.00 | 2023 | Verquvo |
| Glaxosmithkline, LLC. | $31.24 | 2025 | Shingrix, Arexvy |
| Baxter Healthcare | $30.33 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Angiodynamics, INC. | $16.82 | 2023 | Duramax |
| Medtronic, INC. | $16.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Singletary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.